STOCK TITAN

Moolec Science SA Ordinary Shares - MLEC STOCK NEWS

Welcome to our dedicated page for Moolec Science SA Ordinary Shares news (Ticker: MLEC), a resource for investors and traders seeking the latest updates and insights on Moolec Science SA Ordinary Shares stock.

Moolec Science SA (NASDAQ: MLEC) is a pioneering science-based food ingredient company that leads the way in Molecular Farming technology, an innovative method for producing animal proteins in plants. Moolec’s mission is to create unique, sustainable food ingredients by engineering plants with animal protein genes. The company focuses on upgrading the taste, nutrition, and affordability of alternative protein products, thereby contributing to a more sustainable and equitable food system.

Moolec's core technology integrates the agronomic efficiency of widely used crops like soybean, safflower, and pea with the functionality of animal proteins, offering a groundbreaking approach to food production. The company's recent achievements include the development of Piggy Sooy™, a soybean platform that produces high amounts of pork protein, significantly enhancing the efficiency of protein production in plants.

With its disruptive innovations, Moolec has established a strong patent portfolio, consisting of over 25 patents (both granted and pending). These patents protect the company's proprietary methods and products, which have applications across various industries, including pharmaceuticals, cosmetics, and diagnostics. Moolec operates internationally, with a diverse team of Ph.D.s and food industry experts working in the United States, Europe, and South America.

Moolec has also recently announced agreements to issue convertible notes totaling approximately $30 million to strategic partners, which will further bolster its financial position and accelerate its R&D and commercialization efforts. Additionally, the company's breakthroughs in regulatory approvals, such as the USDA-APHIS review of Piggy Sooy™, underscore its leadership in the biotech landscape.

Moolec’s forward-looking strategy includes ongoing partnerships, like the one with Grupo Insud and Bioceres Crop Solutions, which provide both financial and operational support. These collaborations are pivotal in advancing Moolec's mission to redefine animal protein production for the betterment of global food security and sustainability.

Rhea-AI Summary
Moolec Science SA (NASDAQ:MLEC) provided its Business Update for the second quarter of Fiscal Year 2024, highlighting advancements in soybean seed propagation, bovine myoglobin gene confirmation in pea seeds, yeast strain development, product marketing at Gulfood 2024, and a Capital Raise of ~$30M. Despite a slight decline in revenues, the company maintains cost efficiency and operational cash utilization. Management expressed confidence in the company's financial position and growth prospects.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.81%
Tags
-
Rhea-AI Summary
Moolec Science SA (NASDAQ:MLEC) announced the release of its Business Update for the Second Quarter Fiscal Year 2024. The live Conference Call with key executives will take place on March 13, 2024, followed by a Q&A session and a presentation. Investors can access the webinar and presentation via the company's Investor Relations website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.11%
Tags
conferences earnings
-
Rhea-AI Summary
Moolec Science SA (NASDAQ:MLEC) reported a business update for the first quarter of Fiscal Year 2024, highlighting a 92% QoQ revenue increase to $1.74 million, successful progress in scientific development, and operational milestones achieved in their Molecular Biology Lab. The company is preparing for commercialization and has seen positive results in the propagation of their soybeans, with high levels of porcine myoglobin protein confirmed for a second consecutive generation.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.69%
Tags
Rhea-AI Summary
Moolec Science SA (NASDAQ:MLEC) will release its Business Update for the First Quarter Fiscal Year 2024 on December 14, 2023. The live Conference Call, hosted by CEO Gastón Paladini, CFO José López Lecube, and CSO Amit Dhingra, will provide insights into the company's performance and future plans.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.4%
Tags
conferences earnings
-
Rhea-AI Summary
Moolec Science reports Business Update for Q4 FY2023, highlighting achievements and financial support
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.99%
Tags
none
-
Rhea-AI Summary
Moolec Science to release Business Update for Fiscal Year 2023
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.67%
Tags
conferences earnings
Rhea-AI Summary
Moolec Science announces agreements for convertible notes and supply agreement with Grupo Insud and Bioceres Crop Solutions
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
13.43%
Tags
none
-
Rhea-AI Summary
Moolec Science, a food ingredient company focused on producing animal proteins in plants, has achieved an outstanding milestone in its Meat Replacements Program. Its new product, Piggy Sooy, produced a significantly high amount of pork protein, exceeding initial projections by 4x. This achievement has led to the renaming of the soybean platform to Piggy Sooy. Moolec has filed a new patent to secure a regulatory pathway. The breakthrough showcases the efficiency of plants in producing animal proteins, potentially improving the company's business model. Moolec also highlighted the potential for commercialization within the traditional meat industry.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
13.1%
Tags
none
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.57%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.92%
Tags
conferences

FAQ

What is the current stock price of Moolec Science SA Ordinary Shares (MLEC)?

The current stock price of Moolec Science SA Ordinary Shares (MLEC) is $0.85 as of December 20, 2024.

What is the market cap of Moolec Science SA Ordinary Shares (MLEC)?

The market cap of Moolec Science SA Ordinary Shares (MLEC) is approximately 33.1M.

What is Moolec Science SA?

Moolec Science SA is a science-based food ingredient company focused on producing animal proteins in plants through Molecular Farming technology.

What is Molecular Farming?

Molecular Farming is a technology that enables the production of animal proteins in plants, combining plant-based efficiency with the functionality of animal proteins.

What is Piggy Sooy™?

Piggy Sooy™ is Moolec's innovative soybean platform that produces high amounts of pork protein, significantly enhancing protein production efficiency in plants.

Where does Moolec operate?

Moolec operates internationally with a presence in the United States, Europe, and South America.

What are Moolec’s recent financial achievements?

Moolec has entered agreements to issue convertible notes totaling approximately $30 million, enhancing its financial position and supporting its R&D projects.

What are some of Moolec's strategic partnerships?

Moolec has strategic partnerships with Grupo Insud and Bioceres Crop Solutions, providing financial and operational support to advance its mission.

What industries can benefit from Moolec's technology?

Moolec's technology has applications in various industries, including food, pharmaceuticals, cosmetics, and diagnostics.

What recent regulatory approval has Moolec achieved?

Moolec's Piggy Sooy™ received USDA-APHIS regulatory approval, making it the first Molecular Farming company to achieve such a milestone.

How many patents does Moolec hold?

Moolec holds over 25 patents (both granted and pending) for its Molecular Farming technology.

What is the mission of Moolec Science SA?

Moolec's mission is to create unique food ingredients by engineering plants with animal protein genes, aiming to make food production more sustainable and equitable.

Moolec Science SA Ordinary Shares

Nasdaq:MLEC

MLEC Rankings

MLEC Stock Data

33.09M
7.35M
81.53%
0.12%
0.47%
Biotechnology
Healthcare
Link
United States of America
Luxembourg